Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 18.05.2026 4 Ann Neurol 1 BMC Neurol 2 Exp Brain Res 1 Exp Neurol 7 J Neural Transm (Vienna) 2 Lancet Neurol 3 Mov Disord 3 Neurobiol Dis 1 Neurol Clin Pract 2 Neurology 1 Neuropsychology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. TIMMERMANS NA, Bucur IG, Soriano DC, Post E, et al
   Daily-Life, Sensor-Derived Tremor Measures Are Sensitive to Progression in Early Parkinson's Disease.
   Ann Neurol. 2026 May 12. doi: 10.1002/ana.78236.
   PubMed         Abstract available
   
   
2. WEINTRAUB D, Dobkin RD, York MK, Chahine LM, et al
   Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative.
   Ann Neurol. 2026 May 13. doi: 10.1002/ana.78254.
   PubMed         Abstract available
   
   
3. BROWN EG, Chahine LM, Dobkin RD, Simuni T, et al
   Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.
   Ann Neurol. 2026 May 14. doi: 10.1002/ana.78246.
   PubMed         Abstract available
   
   
4. ARCA VM, Jurkeviciene J, Cullinane P, Wrigley S, et al
   Diagnostic, Prognostic Value, and Pathological Associations of Levodopa Responsiveness in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
   Ann Neurol. 2026 May 14. doi: 10.1002/ana.78257.
   PubMed         Abstract available
   
   

   
   BMC Neurol

5. SAIDVALIYEV F, Pulatova D, Kilichev I, Yusupov A, et al
   Serum ferritin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio are associated with levodopa-induced dyskinesia severity in Parkinson's disease.
   BMC Neurol. 2026 May 11. doi: 10.1186/s12883-026-04963.
   PubMed         Abstract available
   
   

   
   Exp Brain Res

6. BIONI V, Lima AC, Cunha DMG, Goncalves N, et al
   Predictive validation of the repeated low-dose reserpine rodent model of parkinsonism.
   Exp Brain Res. 2026;244:115.
   PubMed         Abstract available
   
   
7. DAS PEKTEZEL L, Panpalli Ates M, Comoglu SS, Ulker AC, et al
   Subthalamic nucleus deep brain stimulation and associations with attention and processing speed in Parkinson's disease.
   Exp Brain Res. 2026;244:116.
   PubMed         Abstract available
   
   

   
   Exp Neurol

8. CALLEJA-CONDE J, Echeverry-Alzate V, Sanz-SanCristobal M, Alonso-Gil S, et al
   Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease.
   Exp Neurol. 2026 May 12:115822. doi: 10.1016/j.expneurol.2026.115822.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

9. SCHRAG A, Embleton-Thirsk A, Carroll C, Serfaty M, et al
   Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD).
   J Neural Transm (Vienna). 2026 May 8. doi: 10.1007/s00702-026-03170.
   PubMed         Abstract available
   
   
10. JELLINGER K, Compta Y
    New insight into atypical parkinsonism: a special issue in memory of Gregor Wenning (1964-2024).
    J Neural Transm (Vienna). 2026 May 11. doi: 10.1007/s00702-026-03144.
    PubMed        
    
    
11. METTA V, Mridula R, Hosurkar G, Wadia P, et al
    Correction: Deep brain stimulation for Parkinson's disease in India: an expert consensus on availability, affordability, and eligibility by the Parkinson's research alliance India (PRAI).
    J Neural Transm (Vienna). 2026 May 11. doi: 10.1007/s00702-026-03154.
    PubMed        
    
    
12. BHARDWAJ M, Prasad S, Kumar KJ, Nagaraj T, et al
    Visual memory in Parkinson's Disease: a non-graphomotor approach to assessment.
    J Neural Transm (Vienna). 2026 May 14. doi: 10.1007/s00702-026-03181.
    PubMed         Abstract available
    
    
13. RINALDI D, Galli S, Imbalzano G, Budicin S, et al
    Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson's disease patients: the role of clinical and demographic factors.
    J Neural Transm (Vienna). 2026 May 14. doi: 10.1007/s00702-026-03164.
    PubMed         Abstract available
    
    
14. TABUZO-ACUIN MMB, Jamora RDG, Castillo-Carandang NT
    Caring for persons with X-linked dystonia-parkinsonism in Metro Manila: insights into the burden of family caregivers.
    J Neural Transm (Vienna). 2026 May 14. doi: 10.1007/s00702-026-03177.
    PubMed         Abstract available
    
    
15. BAUTISTA JM, Quanico CJ, Cataniag P, Guillermo JG, et al
    Detecting the seeds of Parkinson's disease: the evolution of alpha?synuclein seed amplification assay as a clinical biomarker.
    J Neural Transm (Vienna). 2026 May 14. doi: 10.1007/s00702-026-03174.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

16. THE LANCET NEUROLOGY
    The US Parkinson's disease community demands prevention.
    Lancet Neurol. 2026;25:533.
    PubMed        
    
    
17. MENOZZI E, Toffoli M, Deleidi M, Di Monte DA, et al
    New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.
    Lancet Neurol. 2026;25:602-614.
    PubMed         Abstract available
    
    

    
    Mov Disord

18. LATIMER C, Lorenzo-Betancor O, Chen DH, Su K, et al
    Heterogenous Neuropathology in a Pedigree with RAB39B-Related Parkinson's Disease.
    Mov Disord. 2026 May 15. doi: 10.1002/mds.70341.
    PubMed         Abstract available
    
    
19. SILVEIRA-MORIYAMA L, Bruno MK, Schneider SA, Ganos C, et al
    Addressing Care Partner Burden from the Underrecognition of Iatrogenic Sexual Behavior Changes in Parkinson's Disease.
    Mov Disord. 2026 May 11. doi: 10.1002/mds.70315.
    PubMed        
    
    
20. PENG W, Zhao R, Huang Z, Zhou J, et al
    Qihuang Needle Therapy for Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.
    Mov Disord. 2026 May 9. doi: 10.1002/mds.70343.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

21. SICILIANO M, De Micco R, Pirozzi MA, Goldman JG, et al
    From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture.
    Neurobiol Dis. 2026;225:107438.
    PubMed         Abstract available
    
    
22. RONG S, Yang R, Li Z, Cui X, et al
    Differential cholinergic white matter microstructural alterations in multiple system atrophy and Parkinson's disease.
    Neurobiol Dis. 2026 May 12:107449. doi: 10.1016/j.nbd.2026.107449.
    PubMed         Abstract available
    
    
23. HANI M, Mahmoudi S, Benjelloun M
    Decoding Parkinson's progression: A multi-modal SuStaIn ensemble approach validated on real-world PPMI data.
    Neurobiol Dis. 2026 May 11:107435. doi: 10.1016/j.nbd.2026.107435.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

24. HILLEN MA, Kurpershoek E, Huisman MHB, Pleizier CM, et al
    Clinician Communication About Uncertainty During Parkinson Disease Diagnostic Consultations.
    Neurol Clin Pract. 2026;16:e200613.
    PubMed         Abstract available
    
    

    
    Neurology

25. NIEMI KJ, Jaakkola E, Myller EM, Eklund MRE, et al
    Striatal Dopamine Transporter and Rest Tremor in Parkinson Disease: A Clinical Validation.
    Neurology. 2026;106:e218131.
    PubMed        
    
    
26. IQBAL MM, Tarolli C, Risco J, Wensel A, et al
    Clinical Reasoning: A Woman With Parkinson Disease, Dyskinesia, Rhabdomyolysis, Subcutaneous Emphysema, and Pneumomediastinum.
    Neurology. 2026;106:e218064.
    PubMed         Abstract available
    
    

    
    Neuropsychology

27. VARELA JL, Margolis SA, Akbar U, Prieto S, et al
    Subjective and objective cognition in early-stage, treatment-naive Parkinson's disease: Relationships with mood.
    Neuropsychology. 2026 May 11. doi: 10.1037/neu0001097.
    PubMed         Abstract available
    
    

    
    PLoS One

28. RATHOD VU, Amrutkar SS, Patil KA, Londhe AD, et al
    A modular deep learning architecture for interpretable disease prediction across tabular clinical and biometric datasets.
    PLoS One. 2026;21:e0348670.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum